Related references
Note: Only part of the references are listed.Antitumoral Activity of Rapamycin Mediated Through Inhibition of HIF-1alpha and VEGF in Hepatocellular Carcinoma
Wei Wang et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1
Gianfranco Distefano et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Store-operated cyclic AMP signalling mediated by STIM1
Konstantinos Lefkimmiatis et al.
NATURE CELL BIOLOGY (2009)
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease
Domenico Alvaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The effect of tyrosine kinase inhibitors, tyrphostins: AG1024 and SU1498, on autocrine growth of prostate cancer cells (DU145)
Joanna Kisielewska et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2008)
The RSK factors of activating the Ras/MAPK signaling cascade
Audrey Carriere et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Sirolimus reduces polycystic liver volume in ADPKD patients
Qi Qian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion
Sergio A. Gradilone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis
Domenico Alvaro et al.
ANNALS OF INTERNAL MEDICINE (2007)
Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases
Ala'eddin Jebreel et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2007)
RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation
Philippe P. Roux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2
Georgia I. Anyatonwu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells
P. Frost et al.
ONCOGENE (2007)
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis
Paolo Onori et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease
Ming Wu et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2007)
Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling
Anatoliy I. Masyuk et al.
GASTROENTEROLOGY (2006)
Estrogens and the pathophysiology of the biliary tree
Domenico Alvaro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases
L Fabris et al.
HEPATOLOGY (2006)
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
JM Shillingford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)
PR Wahl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases
VE Torres et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The consortium for radiologic imaging studies of polycystic kidney disease cohort
Kyongtae T. Bae et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling
Y Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis
D Alvaro et al.
JOURNAL OF HEPATOLOGY (2005)
Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I
C Treins et al.
MOLECULAR ENDOCRINOLOGY (2005)
Pathophysiology of cholangiopathies
M Strazzabosco et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease
YX Tao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase
PP Roux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys
T Yamaguchi et al.
KIDNEY INTERNATIONAL (2003)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action
CY Guo et al.
GENESIS (2002)
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
M Hidalgo et al.
ONCOGENE (2000)
Share Paper
